MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE:BCR) today reported 2016 third quarter financial results. Third quarter 2016 net sales were $941.9 million, an increase of 9 percent over the prior-year period on an as-reported basis. Excluding the impact of foreign exchange, third quarter 2016 net sales increased 10 percent over the prior-year period.
For the third quarter 2016, net sales in the U.S. were $646.0 million, an increase of 7 percent over the prior-year period. Net sales outside the U.S. were $295.9 million, an increase of 14 percent from the prior-year period on an as-reported basis. Excluding the impact of foreign exchange, third quarter 2016 net sales outside the U.S. increased 17 percent over the prior-year period.
For the third quarter 2016, net income was $96.4 million and diluted earnings per share were $1.27, an increase of 212 percent and 209 percent, respectively, as compared to third quarter 2015 results. Adjusting for amortization of intangibles and certain items that affect the comparability of results between periods, as detailed in the tables below, third quarter 2016 net income was $199.5 million and diluted earnings per share were $2.64, an increase of 14 percent and 16 percent, respectively, as compared to third quarter 2015 results.
Timothy M. Ring, chairman and chief executive officer, commented, “The results this quarter demonstrate the continued strength of the economic engine of our business. We continue to increase investments in geographies, products, platforms, and programs that we believe can drive revenue growth longer term. During this period of increased investment in 2016, we have also been able to deliver attractive bottom-line returns for shareholders. We have increased our full-year financial guidance every quarter this year, and we are doing so again today. We expect a strong finish to what has been a very strong year for us so far.”
In conjunction with the third quarter results, the company is again increasing 2016 financial guidance. For the full year 2016, net sales are forecasted to increase between 8 percent and 9 percent on an as-reported basis. Excluding the impact of foreign exchange, full year 2016 net sales are forecasted to increase between 9 percent and 10 percent over 2015. Full year 2016 diluted earnings per share, after adjusting for amortization of intangibles and certain items that affect comparability between periods are projected to be between $10.23 and $10.28, representing growth of 13 percent compared to full year 2015 results.
C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, NJ, is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.

